# Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus

> **NCT04599075** · PHASE4 · COMPLETED · sponsor: **Gianna Wilkie** · enrollment: 70 (actual)

## Conditions studied

- Type 1 Diabetes
- Pregnancy, High Risk

## Interventions

- **DRUG:** Insulin
- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT04599075
- **Lead sponsor:** Gianna Wilkie
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-15
- **Primary completion:** 2023-05-01
- **Final completion:** 2023-05-02
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2024-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04599075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04599075, "Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04599075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*